Keratinocyte growth factor enhanced immune reconstitution in murine allogeneic umbilical cord blood cell transplant

References

• GluckmanE, RochaV. Cord blood transplantation: state of the art. Haematologica 2009;94:51–454.
   Web of Science ®Google Scholar
• FrassoniF, GualandiF, PodestàM, et al. Direct intrabone transplant of unrelated cord-blood cells in acute leukaemia: a phase I/II study. Lancet Oncol 2008;9:831–839.
   PubMed Web of Science ®Google Scholar
• BroxmeyerHE. Biology of cord blood cells and future prospects for enhanced clinical benefit. Cytotherapy 2005;7:209–218.
   PubMed Web of Science ®Google Scholar
• KomanduriKV, JohnLS, de LimaM, et al. Delayed immune reconstitution after cord blood transplantation is characterized by impaired thymopoiesis and late memory T-cell skewing. Blood 2007;110:4543–4551.
   PubMed Web of Science ®Google Scholar
• SzabolcsP, NiedzwieckiD. Immune reconstitution in children after unrelated cord blood transplantation. Biol Blood Marrow Transplant 2008;14:66–72.
   PubMed Web of Science ®Google Scholar
• TakamiA, MochizukiK, AsakuraH, et al. High incidence of cytomegalovirus reactivation in adult recipients of an unrelated cord blood transplant. Haematologica 2005;90:1290–1292.
   PubMed Web of Science ®Google Scholar
• MigishimaF, OikawaA, KondoS, et al. Full reconstitution of hematopoietic system by murine umbilical cord blood. Transplantation 2003;75:1820–1826.
   PubMed Web of Science ®Google Scholar
• ChenBJ, CuiX, SempowskiGD, et al. A comparison of murine T-cell-depleted adult bone marrow and full-term fetal blood cells in hematopoietic engraftment and immune reconstitution. Blood 2002;99:364–731.
   PubMed Web of Science ®Google Scholar
• OoiJ, IsekiT, TakahashiS, et al. Unrelated cord blood transplantation for adult patients with de novo acute myeloid leukemia. Blood 2004;103:489–491.
   PubMed Web of Science ®Google Scholar
• KurtzbergJ, PrasadVK, CarterSL, et al. Results of the Cord Blood Transplantation Study (COBLT): clinical outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with hematologic malignancies. Blood 2008;112:4318–4327.
   PubMed Web of Science ®Google Scholar
• NashRA, GooleyT, DavisC, et al. The problem of thrombocytopenia after hematopoietic stem cell transplantation. Oncologist 1996;1:371–380.
   PubMedGoogle Scholar
• AndersonG, LanePJ, JenkinsonEJ. Generating intrathymic microenvironments to establish T-cell tolerance. Nat Rev Immunol 2007;7:954–963.
   PubMed Web of Science ®Google Scholar
• MinD, TaylorPA, Panoskaltsis-MortariA, et al. Protection from thymic epithelial cell injury by keratinocyte growth factor: a new approach to improve thymic and peripheral T-cell reconstitution after bone marrow transplantation. Blood 2002;99:4592–4600.
   PubMed Web of Science ®Google Scholar
• StarrTK, JamesonSC, HogquistKA. Positive and negative selection of T cells. Annu Rev Immunol 2003;21:139–176.
   PubMed Web of Science ®Google Scholar
• RossiS, BlazarBR, FarrellCL, et al. Keratinocyte growth factor preserves normal thymopoiesis and thymic microenvironment during experimental graft-versus-host disease. Blood 2002;100:682–691.
   PubMed Web of Science ®Google Scholar
• RossiSW, JekerLT, UenoT, et al. Keratinocyte growth factor (KGF) enhances postnatal T-cell development via enhancements in proliferation and function of thymic epithelial cells. Blood 2007;109:3803–3811.
   PubMed Web of Science ®Google Scholar
• Panoskaltsis-MortariA, LaceyDL, ValleraDA, BlazarBR. Keratinocyte growth factor administered before conditioning ameliorates graft-versus-host disease after allogeneic bone marrow transplantation in mice. Blood 1998;92:3960–3967.
   PubMed Web of Science ®Google Scholar
• TalvensaariK, ClaveE, DouayC, et al. A broad T-cell repertoire diversity and an efficient thymic function indicate a favorable long-term immune reconstitution after cord blood stem cell transplantation. Blood 2002;99:1458–1464.
   PubMed Web of Science ®Google Scholar
• DouekDC, McFarlandRD, KeiserPH, et al. Changes in thymic function with age and during the treatment of HIV infection. Nature 1998;396:690–695.
   PubMed Web of Science ®Google Scholar
• KrengerW, SchmidlinH, CavadiniG, HolländerGA. On the relevance of TCR rearrangement circles as molecular markers for thymic output during experimental graft-versus-host disease. J Immunol 2004;172:7359–7367.
   PubMed Web of Science ®Google Scholar
• ChenG, WuD, WangY, et al. Expanded donor natural killer cell and IL-2, IL-15 treatment efficacy in allogeneic hematopoietic stem cell transplantation. Eur J Haematol 2008;81:226–235.
   PubMed Web of Science ®Google Scholar
• CookeKR, KobzikL, MartinTR, et al. An experimental model of idiopathic pneumonia syndrome after bone marrow transplantation: I. The roles of minor H antigens and endotoxin. Blood 1996;88:3230–3239.
   PubMed Web of Science ®Google Scholar
• BroersA, SluijsSJ, SpitsH, et al. Interleukin-7 improves T-cell recovery after experimental T-cell-depleted bone marrow transplantation in T-cell-deficient mice by strong expansion of recent thymic emigrants. Blood 2003;102:1534–1540.
   PubMed Web of Science ®Google Scholar
• LiYQ, ChenSH, YangLJ, et al. TRAV and TRBV repertoire, clonality and the proliferative history of umbilical cord blood T-cells. Transplant Immunol 2007;18:151–158.
   PubMed Web of Science ®Google Scholar
• MillerJS, WeisdorfDJ, BurnsLJ, et al. Lymphodepletion followed by donor lymphocyte infusion (DLI) causes significantly more acute graft-versus-host disease than DLI alone. Blood 2007;110:2761–2763.
   PubMed Web of Science ®Google Scholar
• DoderoA, CarnitiC, RaganatoA, et al. Haploidentical stem cell transplantation after a reduced-intensity conditioning regimen for the treatment of advanced hematologic malignancies: posttransplantation CD8-depleted donor lymphocyte infusions contribute to improve T-cell recovery. Blood 2009;113:4771–4779.
   PubMed Web of Science ®Google Scholar
• MarksDI, LushR, CavenaghJ, et al. The toxicity and efficacy of donor lymphocyte infusions given after reduced-intensity conditioning allogeneic stem cell transplantation. Blood 2002;100:3108–3114.
   PubMed Web of Science ®Google Scholar
• SolomonSR, MielkeS, SavaniBN, et al. Selective depletion of alloreactive donor lymphocytes: a novel method to reduce the severity of graft-versus-host disease in older patients undergoing matched sibling donor stem cell transplantation. Blood 2005;106:1123–1129.
   PubMed Web of Science ®Google Scholar
• WagnerJE, GluckmanE. Umbilical cord blood transplantation: the first 20 years. Semin Hematol 2010;47:3–12.
   PubMed Web of Science ®Google Scholar
• ReddyP, NegrinR, HillGR. Mouse models of bone marrow transplantation. Biol Blood Marrow Transplant 2008;14:129–135.
   PubMed Web of Science ®Google Scholar
• PatelSR, CadwellCM, MedfordA, ZimringJC. Transfusion of minor histocompatibility antigen-mismatched platelets induces rejection of bone marrow transplants in mice. J Clin Invest 2009;119:2787–2794.
   PubMed Web of Science ®Google Scholar
• Duran-StruuckR, DyskoRC. Principles of bone marrow transplantation (BMT): providing optimal veterinary and husbandry care to irradiated mice in BMT studies. J Am Assoc Lab Anim Sci 2009;48:11–22.
   PubMed Web of Science ®Google Scholar
• OoiJ, IsekiT, TakahashiS, et al. A clinical comparison of unrelated cord blood transplantation and unrelated bone marrow transplantation for adult patients with acute leukaemia in complete remission. Br J Haematol 2002;118:140–143.
   PubMed Web of Science ®Google Scholar
• FrangoulisB, BesluauD, ChopinM, DegosL, PlaM. Immune response to H-2 class I antigens on platelets. I. Immunogenicity of platelet class I antigens. Tissue Antigens 1988;32:46–54.
   PubMed Web of Science ®Google Scholar
• BernsteinID, BoydRL, van den BrinkM. Clinical strategies to enhance posttransplant immune reconstitution. Biol Blood Marrow Transplant 2008;14:94–99.
   PubMed Web of Science ®Google Scholar
• SeggewissR, LoréK, GuenagaFJ, et al. Keratinocyte growth factor augments immune reconstitution after autologous hematopoietic progenitor cell transplantation in rhesus macaques. Blood 2007;110:441–449.
   PubMed Web of Science ®Google Scholar
• KrijanovskiOI, HillGR, CookeKR, et al. Keratinocyte growth factor separates graft-versus-leukemia effects from graft-versus-host disease. Blood 1999;94:825–831.
   PubMed Web of Science ®Google Scholar
• AlpdoganÖ, HubbardVM, SmithOM, et al. Keratinocyte growth factor (KGF) is required for postnatal thymic regeneration. Blood 2006;107:2453–2460.
   PubMed Web of Science ®Google Scholar
• KellyRM, GorenEM, TaylorPA, et al. Short-term inhibition of p53 combined with keratinocyte growth factor improves thymic epithelial cell recovery and enhances T-cell reconstitution after murine bone marrow transplantation. Blood 2010;115:1088–1097.
   PubMed Web of Science ®Google Scholar
• KellyRM, HighfillSL, Panoskaltsis-MortariA, et al. Keratinocyte growth factor and androgen blockade work in concert to protect against conditioning regimen-induced thymic epithelial damage and enhance T-cell reconstitution after murine bone marrow transplantation. Blood 2008;111:5734–5744.
   PubMed Web of Science ®Google Scholar
• MackallCL, BareCV, GrangerLA, et al. Thymic-independent T cell regeneration occurs via antigen-driven expansion of peripheral T cells resulting in a repertoire that is limited in diversity and prone to skewing. J Immunol 1996;156:4609–4616.
   PubMed Web of Science ®Google Scholar
• JenqRR, KingCG, VolkC, et al. Keratinocyte growth factor enhances DNA plasmid tumor vaccine responses after murine allogeneic bone marrow transplantation. Blood 2009;113:1574–1580.
   PubMed Web of Science ®Google Scholar